Comparative Outcomes of Standalone Xen63 Gel Stent and Preserflo Microshunt Implantation: A Multicenter Study
Ticiana De Francesco, Huixin Anna Zhang, Vital P Costa, Iqbal Ike K Ahmed · 2026
Read Comparative Outcomes of Standalone Xen63 Gel Stent and Preserflo Microshunt Implantation: A Multicenter Study by Ticiana De Francesco, Huixin Anna Zhang, Vital P Costa, Iqbal Ike K Ahmed (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13271431.txt.
Description
Ticiana De Francesco is lead author of a 2026 multicentre study comparing two tiny drainage devices for glaucoma, the Xen63 gel stent and the Preserflo microshunt. Both lower eye pressure by draining fluid. Both were implanted alone, with a drug to limit scarring, in this study looking back at past cases.
At twelve months, complete success was about sixty-two percent for Xen63 and about seventy-four percent for Preserflo. Complete success meant pressure controlled without glaucoma medicines under strict rules. That gap was not statistically clear. Complications were more frequent with Xen63, at about sixty-two percent against about twenty-nine percent. Reoperations were also more common, at about seventeen percent against four percent. Pressure reduction and medicine burden were otherwise comparable.
Catalog record
| CREATOR | Ticiana De Francesco, Huixin Anna Zhang, Vital P Costa, Iqbal Ike K Ahmed |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51793 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |